These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 7748068)

  • 1. Discrimination of Epstein-Barr virus-related posttransplant lymphoproliferations from acute rejection in lung allograft recipients.
    Rosendale B; Yousem SA
    Arch Pathol Lab Med; 1995 May; 119(5):418-23. PubMed ID: 7748068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.
    Calabrese F; Loy M; Lunardi F; Marino D; Aversa SM; Rea F
    Transpl Infect Dis; 2010 Aug; 12(4):342-6. PubMed ID: 20030794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder.
    Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE
    Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.
    Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F
    Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection.
    Rizkalla KS; Asfar SK; McLean CA; Garcia BM; Wall WJ; Grant DR
    Mod Pathol; 1997 Jul; 10(7):708-15. PubMed ID: 9237182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
    Meehan SM; Domer P; Josephson M; Donoghue M; Sadhu A; Ho LT; Aronson AJ; Thistlethwaite JR; Haas M
    Hum Pathol; 2001 Feb; 32(2):205-15. PubMed ID: 11230708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart allograft involvement with Epstein-Barr virus-associated posttransplant lymphoproliferative disorder.
    Abu-Farsakh H; Cagle PT; Buffone GJ; Bruner JM; Weilbaecher D; Greenberg SD
    Arch Pathol Lab Med; 1992 Jan; 116(1):93-5. PubMed ID: 1310382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simian virus 40 in posttransplant lymphoproliferative disorders.
    Vilchez RA; Jauregui MP; Hsi ED; Novoa-Takara L; Chang CC
    Hum Pathol; 2006 Sep; 37(9):1130-6. PubMed ID: 16938517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-DNA load monitoring late after lung transplantation: a surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression.
    Bakker NA; Verschuuren EA; Erasmus ME; Hepkema BG; Veeger NJ; Kallenberg CG; van der Bij W
    Transplantation; 2007 Feb; 83(4):433-8. PubMed ID: 17318076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disorder in liver allograft biopsies: a comparison of three methods for the demonstration of Epstein-Barr virus.
    Lones MA; Shintaku IP; Weiss LM; Thung SN; Nichols WS; Geller SA
    Hum Pathol; 1997 May; 28(5):533-9. PubMed ID: 9158700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.
    Drachenberg CB; Abruzzo LV; Klassen DK; Bartlett ST; Johnson LB; Kuo PC; Kumar D; Papadimitriou JC
    Hum Pathol; 1998 Jun; 29(6):569-77. PubMed ID: 9635676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. bcl-2 protein is strongly expressed in post-transplant lymphoproliferative disorders.
    Chetty R; Biddolph S; Kaklamanis L; Cary N; Stewart S; Giatromanolaki A; Gatter K
    J Pathol; 1996 Nov; 180(3):254-8. PubMed ID: 8958801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT; Hodinka RL; Salhany KE; Lavi E; Rostami A; Tomaszewski JE
    Mod Pathol; 1996 Jun; 9(6):621-30. PubMed ID: 8782198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
    Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
    Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
    Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus detection in sequential biopsies from patients with a posttransplant lymphoproliferative disorder.
    Lager DJ; Burgart LJ; Slagel DD
    Mod Pathol; 1993 Jan; 6(1):42-7. PubMed ID: 8381232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN; Douglas LP; Andreadis C; Arnoldi S; Svoboda J; Kotloff RM; Hadjiliadis D; Sager JS; Woo YJ; Pochettino A; Schuster SJ; Stadtmauer EA; Tsai DE
    J Heart Lung Transplant; 2007 Aug; 26(8):839-44. PubMed ID: 17692789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB; Muirhead N; Jevnikar AM; Leckie SH; Khakhar AK; Luke PP; Rizkalla KS; Hollomby DJ; House AA
    Transplantation; 2003 Mar; 75(6):851-6. PubMed ID: 12660514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M; Desai DM; Cox KL; Berquist WE; Esquivel CO; Millan MT
    Pediatr Transplant; 2004 Jun; 8(3):267-72. PubMed ID: 15176965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.